Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

usiness are accelerating driven by the Company's IMPACT accounts.  Haemonetics expects full year revenue growth of approximately 25%.  

Software Solutions revenue was $16.6 million for the quarter, up 101%, and $49.2 million year to date, up 90%.  Software Solutions growth was primarily impacted by our Global Med acquisition.  Organic software growth was 14% in the quarter and 6% year to date.  Haemonetics expects full year revenue growth of approximately 95%.

Equipment and Other revenue was $16.1 million for the quarter, up 16%, and $43.3 million year to date, up 22%.  Year to date equipment growth was impacted by the SEBRA® acquisition.  Organic equipment growth year to date was 14%.  Haemonetics expects full year revenue growth of 5-8% as we compare to Q4 fiscal 10 Equipment and Other sales of $18.8 million which included $2.5 million of one-time royalty revenue.

In the quarter, North American sales were up 6%, European sales were up 10%, Japanese sales were down 3%, and Asian sales were up 22%.  Year to date, North American sales were up 6%, European sales were up 6%, Japanese sales were up 1% and Asian sales were up 26%.

CONFERENCE CALLHaemonetics will host a webcast on Monday, January 31st at 10:00am Eastern to discuss these results.  Interested parties can participate at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=3643178

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes a
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
2. Neogen Reports 33% Increase in Net Income
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
7. GeneLink Reports Third Quarter Results
8. Imagenetix, Inc. Reports Second Quarter 2011 Results
9. Transgenomic Reports Third Quarter Financial Results
10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 After the boom of the ... next beverage craze is going to be the stress ... can use Stress Relief energy pattern which can be ... of a beverage, including minerals, herbs and liquids. Stress ... that power into rapid recovery and helping to adapt ...
(Date:8/27/2014)... Ohio (PRWEB) August 27, 2014 ... from Cleveland's University School participated in ... Case Western Reserve University’s School of Medicine . ... students with an unparalleled professional experience in the ... School of Medicine faculty and students for both ...
(Date:8/26/2014)... 26, 2014 An analysis by Replikins, Ltd. ... Mers CoV virus strains has revealed extensive ... 2012.  This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... NHS hospitals with surgery validation using its Stratasys Objet24 and ... Performing surgery on 3D printed models prior to operations reduces ... an effective aid for both patient and surgeon   ... ), a global leader of 3D printing and additive manufacturing ...
Breaking Biology Technology:Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5
... Aperio , ... that improve patient care, and Definiens , the ... in which Aperio will market Definiens Tissue Studio™ ... digital pathology, on a worldwide, non-exclusive basis. ...
... 2011 SeraCare Life Sciences, Inc. (NASDAQ: ... products and services to facilitate the discovery, development and ... election of Joseph Nemmers and Kevin Hrusovsky to its ... has been appointed to the position of Chairman of ...
... OncoSec Medical Inc. (OTCBB: ONCS), a therapeutic oncology ... tumor cancers that have unmet medical needs, announced ... leadership team. Formed earlier this year, OncoSec expects ... tumor-destroying, tissue-sparing ElectroOncology therapies before the end of ...
Cached Biology Technology:Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 2Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 3Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 4SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4
(Date:8/27/2014)... a new skill is easier when it is related ... trained pianist might learn a new melody more easily ... Neural engineers from the Center for the Neural Basis ... Pittsburgh and Carnegie Mellon Universityhave discovered a fundamental constraint ... Published as the cover story in the Aug. 28, ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... N.C. -- When we want to listen carefully to ... The second thing we do is stop moving altogether. ... sounds generated by our own movements. , This interplay ... in the brain. Indeed, indirect evidence has long suggested ... influences the auditory cortex, which gives rise to our ...
Breaking Biology News(10 mins):Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... how two closely related proteins guide projections from nerve ... axons as they navigate the most miniscule and frenetic ... connections. The discovery, reported April 28 in the ... the "semaphorin" family of guidance cues are crucial for ...
... for coeliac disease has shown promising results for treating coeliac ... to move to Phase II trials within the next year. ... the safety, tolerability and bioactivity of the vaccine Nexvax2, which ... autoimmune disease caused by an immune reaction to the gluten ...
... of Global Change Biology Bioenergy outlines a ... issues surrounding the rapidly evolving race to develop biofuels. ... on Bioethics Working Party on Biofuels, and Scientific Adviser ... the Council,s proposed development of a comprehensive ethical standard ...
Cached Biology News:Johns Hopkins scientists reveal nerve cells' navigation system 2Johns Hopkins scientists reveal nerve cells' navigation system 3Celiac disease vaccine shows promising results in Phase I trial 2
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
... Innovative HL-2000 HybriLinker combines the benefits of a ... self-contained, space saving unit. , ... Laboratory allows crosslinking ,and hybridization at one location ... HL-2000 operate independently of each other , ...
... a wide variety of solvent vapors that can ... condensation flask (GCF400) allows for the collection of ... draining. Rapid cooling time minimizes waiting period., ... solvent changes , -50?C ...
... determined by Biuret Physical form: Solution in ... 7.6, 1 mM MgCl 2 and ... Definition: One unit will hydrolyze 1 μmole ... 9.8 at 37 C. • Concentration: ≥ ...
Biology Products: